The intensity of stomach discomfort varies based on individual sensitivity to GLP-1 activation
It can also be combined with other products from the Active Slimming range for enhanced efficiency
Taken as a once-weekly injection Doses studied so far include: 1 mg, 4 mg, 8 mg, and up to 12 mg Gradual dose increases are used to help the body adjust and reduce side effects Because retatrutide is still in development, the exact dosing schedule could change before it becomes available, but the general approach is expected to feel similar to current GLP-1 medications
Available Strength Side Effects Nausea or vomiting Diarrhea Abdominal pain Headache Fatigue Dizziness Decreased appetite Constipation Interactions Other GLP-1 agonists Medications affecting gastric emptying Insulin Certain antibiotics Oral diabetes drugs (may require adjustments) Warfarin Precautions and Warnings Not to be used in patients with severe renal failure, a history of pancreatitis, or thyroid cancer
KLOW Blend Research Protocols & Administration Dosing in Published Research Research investigations of individual components have employed various dosing strategies that inform potential combination approaches
